FI
Fosun International Portfolio holdings
AUM
$360M
1-Year Return
38.28%
This Quarter Return
+5.35%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.51B
AUM Growth
-$59.4M
(-3.8%)
Cap. Flow
+$93.8M
Cap. Flow
% of AUM
6.19%
Top 10 Holdings %
Top 10 Hldgs %
50.09%
Holding
338
New
32
Increased
81
Reduced
57
Closed
39
Top Buys
| 1 |
CIH
China Index Holdings Limited American Depository Shares
CIH
|
$11.3M |
| 2 |
AbbVie
ABBV
|
$6.72M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$5.3M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$3.06M |
| 5 |
Incyte
INCY
|
$2.92M |
Top Sells
| 1 |
BZUN
Baozun
BZUN
|
$20.3M |
| 2 |
DigitalBridge
DBRG
|
$14.4M |
| 3 |
Brookdale Senior Living
BKD
|
$13.9M |
| 4 |
Vipshop
VIPS
|
$8.37M |
| 5 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$6.37M |
Sector Composition
| 1 | Healthcare | 31.82% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 3.38% |
| 4 | Technology | 2.61% |
| 5 | Communication Services | 2.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
McKesson
MCK
$86B
| $1.07M | 0.07% |
7,985
| – | – |
|
152
Curis
CRIS
$21.4M
| $1.07M | 0.07% |
29,092
+9,249
| +47% | +$339K |
|
153
Amphenol
APH
$138B
| $1.05M | 0.07% |
43,840
| – | – |
|
154
CytomX Therapeutics
CTMX
$346M
| $1.04M | 0.07% |
97,457
+45,012
| +86% | +$478K |
|
155
MEI Pharma
MEIP
$140M
| $995K | 0.07% |
19,826
| – | – |
|
156
UBS Group
UBS
$128B
| $990K | 0.07% |
87,485
-83,440
| -49% | -$944K |
|
157
Advanced Micro Devices
AMD
$263B
| $984K | 0.07% |
+32,000
| New | +$984K |
|
158
Schlumberger
SLB
$53.7B
| $978K | 0.06% |
25,000
-3,200
| -11% | -$125K |
|
159
AT&T
T
$212B
| $973K | 0.06% |
39,058
| – | – |
|
160
Pfizer
PFE
$140B
| $964K | 0.06% |
23,399
+3,795
| +19% | +$156K |
|
161
Spero Therapeutics
SPRO
$120M
| $962K | 0.06% |
86,596
-16,766
| -16% | -$186K |
|
162
T-Mobile US
TMUS
$284B
| $953K | 0.06% |
13,000
| – | – |
|
163
Omnicell
OMCL
$1.52B
| $949K | 0.06% |
+11,000
| New | +$949K |
|
164
Charles Schwab
SCHW
$177B
| $941K | 0.06% |
23,400
+4,400
| +23% | +$177K |
|
|
CHMA
165
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $923K | 0.06% |
+123,954
| New | +$923K |
|
166
Norfolk Southern
NSC
$62.8B
| $905K | 0.06% |
4,680
-410
| -8% | -$79.3K |
|
167
Nasdaq
NDAQ
$54.1B
| $904K | 0.06% |
+28,200
| New | +$904K |
|
168
Philip Morris
PM
$251B
| $896K | 0.06% |
11,500
| – | – |
|
169
Rhythm Pharmaceuticals
RYTM
$6.95B
| $883K | 0.06% |
40,720
+11,000
| +37% | +$239K |
|
|
PRTK
170
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $875K | 0.06% |
227,383
| – | – |
|
171
Oracle
ORCL
$626B
| $832K | 0.05% |
14,655
| – | – |
|
|
SPPI
172
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $830K | 0.05% |
95,246
| – | – |
|
173
Cartesian Therapeutics
RNAC
$260M
| $824K | 0.05% |
14,611
| – | – |
|
174
IBM
IBM
$230B
| $819K | 0.05% |
6,187
| – | – |
|
175
Citigroup
C
$179B
| $818K | 0.05% |
12,000
| – | – |
|